Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Jyotsna Gummadi, Xin Wang & Changqing Xie. (2023) Current Advances in the Treatment of Fibrolamellar Carcinoma of Liver. Journal of Hepatocellular Carcinoma 10, pages 745-752.
Read now
Read now
Articles from other publishers (12)
Travis Zack, Kurt P. Losert, Samantha M. Maisel, Jennifer Wild, Amin Yaqubie, Michael Herman, Jennifer J. Knox, Robert J. Mayer, Alan P. Venook, Atul Butte, Allison F. O’Neill, Ghassan K. Abou-Alfa & John D. Gordan. (2023) Defining incidence and complications of fibrolamellar liver cancer through tiered computational analysis of clinical data. npj Precision Oncology 7:1.
Crossref
Crossref
Ahdab S Bawashkhah, Ghufran A Sindi, Shahad B Almatrafi, Elaf F Obaid & Reda I Bakhsh. (2022) Fibrolamellar Hepatocellular Carcinoma in the Absence of Risk Factors: A Case Report. Cureus.
Crossref
Crossref
Krista Y. Chen, Aleksandra Popovic, David Hsiehchen, Marina Baretti, Paige Griffith, Ranjan Bista, Azarakhsh Baghdadi, Ihab R. Kamel, Sanford M. Simon, Rachael D. Migler & Mark Yarchoan. (2022) Clinical Outcomes in Fibrolamellar Hepatocellular Carcinoma Treated with Immune Checkpoint Inhibitors. Cancers 14:21, pages 5347.
Crossref
Crossref
Tomoki Sempokuya, Arnold Forlemu, Muaataz Azawi, Krixie Silangcruz, Nathalie Khoury, Jihyun Ma & Linda L Wong. (2022) Survival characteristics of fibrolamellar hepatocellular carcinoma: A Surveillance, Epidemiology, and End Results database study. World Journal of Clinical Oncology 13:5, pages 352-365.
Crossref
Crossref
Sachiyo Onishi, Masahiro Tajika, Tsutomu Tanaka, Keisaku Yamada, Tomoyasu Kamiya, Seiji Natsume, Yasuhiro Shimizu & Yasumasa Niwa. (2022) Juvenile Hepatocellular Carcinoma in a Healthy Liver. Internal Medicine 61:10, pages 1531-1536.
Crossref
Crossref
Marzieh Amani, Ali Bavali & Parviz Parvin. (2022) Optical characterization of the liver tissue affected by fibrolamellar hepatocellular carcinoma based on internal filters of laser-induced fluorescence. Scientific Reports 12:1.
Crossref
Crossref
Sandra Kang, Joseph Magliocca, Marty Sellers, Giorgio Roccaro, Wei Zheng, Melina Pectasides, Amber Draper, Jessica Guadagno, Bassel El-Rayes & Mehmet Akce. (2022) Successful Liver Transplantation of Recurrent Fibrolamellar Carcinoma following Clinical and Pathologic Complete Response to Triple Immunochemotherapy: A Case Report. Oncology Research and Treatment 45:7-8, pages 430-437.
Crossref
Crossref
Tiantian Fu, Hong Ding, Chen Xu, Yuli Zhu, Liyun Xue & Feng Lin. (2021) Imaging findings of fibrolamellar hepatocellular carcinomas on ultrasonography: A comparison with conventional hepatocellular carcinomas1. Clinical Hemorheology and Microcirculation 77:1, pages 49-60.
Crossref
Crossref
Sara Gottlieb, Claire O’Grady, Ariel Gliksberg & Paul Kent. (2021) Early Experiences with Triple Immunochemotherapy in Adolescents and Young Adults with High-Risk Fibrolamellar Carcinoma. Oncology 99:5, pages 310-317.
Crossref
Crossref
Consolato M. SergiConsolato M. Sergi. 2020. Pathology of Childhood and Adolescence. Pathology of Childhood and Adolescence
425
549
.
Aakash Desai, Sonia Sandhu, Jin-Ping Lai & Dalbir Singh Sandhu. (2019) Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review. World Journal of Hepatology 11:1, pages 1-18.
Crossref
Crossref
Oscar Suarez, María Perez, Martin Garzon, Rodrigo Daza, Geovanny Hernandez, Carolina Salinas, Jorge Ceballos, Enrique P. de Leon, Jacqueline Mugnier, Oscar Beltrán & Adriana Varón. (2018) Fibrolamellar Hepatocellular Carcinoma and Noncirrhotic Hyperammonemic Encephalopathy. Case Reports in Hepatology 2018, pages 1-6.
Crossref
Crossref